Purchase Order HHSN272201501042P
Award Date 8/11/15
Potential Completion Date 8/14/15
Potential Value $2.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $2,862.40 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL) for the provision of bulk HIV-1 p24. ABL, a foreign-owned, for-profit manufacturer of goods, has been awarded numerous federal contracts and grants, particularly from NIAID and other NIH institutes, to support infectious disease research and development of...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for the production of HIV-1gp120 protein in support of NIAID's preclinical development program. The contract, which does not have a set-aside designation, has a ceiling value of $4,240,924.91 and an ultimate...
- This federal contract award, valued at $2,959,434.41, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for the synthesis and production of an HIV-1 envelope glycopeptide immunogen nanoparticle vaccine as part of NIAID's Preclinical Development Support program. This is a cost-plus-fixed-fee delivery order contract with an ultimate...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL) for R&D and medical support services related to AIDS research. The contract has a ceiling value of $2,857,610.47 and a period of performance through August 29, 2024. This award is not associated with a set-aside program. ABL, a foreign-owned, for-profit...
- This is a $3,017,609 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) for fill-finish, release, and stability testing of HIV-1 gp120 proteins. The contract has an ultimate completion date of April 15, 2025. ABL is a for-profit organization that specializes in the development of biologics, vaccines, and immunotherapies....
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS). The contract, valued at $4,709,463.34, is for NIAID's Preclinical Development Support program focused on the immunoaffinity purification of HIV-1 envelope proteins. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type. This award does not have a...
- Advanced Bioscience Laboratories, Inc. (ABL) has been awarded a firm fixed price purchase order valued at ten thousand six hundred fifty dollars ($10,650) by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. Under this contract, ABL will deliver bulk HIV-1 p24 in ten plate kits to support the agency's research and product development programs. As a prime contractor holding several...
- This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer of goods. The $8,997,298.00 contract supports the production of ALVAC-HIV drug product and diluent as part of NIAID's Preclinical Development Support program. ABL, a contract research and manufacturing...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) for $1,151,180.13. The contract is a delivery order under a larger HIV Microbicides and Biomedical Prevention program that runs from 2016-2021. Under this contract, ABL will perform quality evaluation and certification of a study product to ensure it meets regulatory requirements for use in...
- This federal contract award is to Advanced Bioscience Laboratories, Inc. (ABL) from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The contract is for the performance of toxicity testing for HIV proteins as part of NIAID's Preclinical Development Support program. The contract is a cost-plus-fixed-fee delivery order with a ceiling value of $1,050,558.51 and a period of performance through April 7, 2017....